ArticleJournal of translational medicine2012

The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.

Kenny Chitcholtan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.